The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_001379110.1(SLC9A6):c.516C>T (p.Phe172=)

CA518744234

469637 (ClinVar)

Gene: SLC9A6
Condition: Christianson syndrome
Inheritance Mode: X-linked inheritance (dominant (HP:0001423))
UUID: 80930d02-04a4-47cd-bd49-a427b39b4670

HGVS expressions

NM_001379110.1:c.516C>T
NM_001379110.1(SLC9A6):c.516C>T (p.Phe172=)
NC_000023.11:g.135998550C>T
CM000685.2:g.135998550C>T
NC_000023.10:g.135080709C>T
CM000685.1:g.135080709C>T
NC_000023.9:g.134908375C>T
NG_017160.1:g.18124C>T
ENST00000370695.8:c.672C>T
ENST00000370701.6:c.516C>T
ENST00000630721.3:c.516C>T
ENST00000636092.1:c.516C>T
ENST00000636347.1:c.516C>T
ENST00000637195.1:c.420C>T
ENST00000637234.1:c.516C>T
ENST00000637581.1:c.516C>T
ENST00000643775.1:n.459C>T
ENST00000674809.1:c.459C>T
ENST00000675550.1:n.457C>T
ENST00000675856.1:n.459C>T
ENST00000676043.1:c.459C>T
ENST00000678163.1:c.672C>T
ENST00000370695.6:c.672C>T
ENST00000370698.7:c.576C>T
ENST00000370701.5:c.516C>T
ENST00000627534.2:c.516C>T
NM_001042537.1:c.672C>T
NM_001177651.1:c.516C>T
NM_006359.2:c.576C>T
NM_001330652.1:c.420C>T
NM_001177651.2:c.516C>T
NM_001330652.2:c.420C>T
NM_006359.3:c.576C>T
NM_001042537.2:c.672C>T
NM_001400909.1:c.516C>T
NM_001400910.1:c.516C>T
NM_001400911.1:c.516C>T
NM_001400912.1:c.516C>T
NM_001400913.1:c.420C>T

Likely Benign

Met criteria codes 4
PM2_Supporting BS2 BP4 BP7

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The p.Phe192= variant in SLC9A6 (NM_006359.2) is observed in the hemizygous state in at least 3 unaffected individuals (internal database - GeneDx) (BS2). The p.Phe172= variant in SLC9A6 is absent from gnomAD (PM2_Supporting). The silent p.Phe172= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP4, BP7). In the absence of other pathogenic evidence beyond PM2_Supporting, and because this variant has been observed in 3 unaffected hemizygous individuals, the ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel has agreed to overrule the PM2_Supporting criterion and classified the p.Phe192= variant in SLC9A6 as Likely Benign (BS2, BP4, BP7).
Met criteria codes
PM2_Supporting
The p.Phe192= variant in SLC9A6 is absent from gnomAD (PM2_supporting).
BS2
The p.Phe192= variant is observed in at least 3 unaffected individuals (internal database - GeneDx) (BS2).
BP4
The silent p.Phe192= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP4, BP7).
BP7
The silent p.Phe192= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide
Approved on: 2023-10-13
Published on: 2023-12-11
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.